Journals / Türk Oftalmoloji Dergisi / 2011 / Cilt: 41 - Sayı: 4

Evaluation of cornea and anterior chamber with pentacam in scleroderma cases

Skleroderma olgularında kornea ve ön kamaranın pentacam ile değerlendirilmesi

Pages
221–224
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Scleroderma is a systemic disease that might lead to alterations in corneal biomechanics and refractivity, and these issues need to be investigated with more advanced studies. (Turk J Ophthalmol 2011; 41: 221-4)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the anterior segment structures with Pentacam in scleroderma patients.
📊
Key Findings & Data:Materials and Methods: The 34 eyes (study group) of 17 scleroderma patients who attended our clinic were compared with 40 eyes (control group) of age-matched 20 healthy individuals.
💡
Conclusion & Impact:Conclusion: Scleroderma is a systemic disease that might lead to alterations in corneal biomechanics and refractivity, and these issues need to be investigated with more advanced studies. (Turk J Ophthalmol 2011; 41: 221-4)
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the anterior segment structures with Pentacam in scleroderma patients. Materials and Methods: The 34 eyes (study group) of 17 scleroderma patients who attended our clinic were compared with 40 eyes (control group) of age-matched 20 healthy individuals. Best-corrected visual acuity (BCVA) and intraocular pressure of all cases were measured, and anterior and posterior segment examinations were performed. The central corneal thickness, ante- rior chamber volume, anterior chamber depth, anterior and posterior elevation maps of all cases were evaluated with Pentacam. Parametric values were compared with independent t-test; non-parametric values were calculated with Mann-Whitney U test. Results: The mean age was 51.63±10.74 (range, 28-72) years in the study group (1 male, 16 female) and 51.42±6.74 (range, 40-66) years in the control group (4 male, 16 female). The corneas of the study group were found to be more refractive: the mean K values of the study and the control groups were 44.38±1.38 and 43.47±1.26 D, respectively, p=0.004. The BCVA in the study group was statistically lower than that in the control group (mean BCVA of the study and the control groups: 0.953±0.0915 and 0.992±0.0408, respectively, p=0.001). There was no significant difference between the two groups regard- ing anterior chamber depth, anterior chamber volume and anterior chamber angle. No difference was found in central corneal thickness, intraocular pressure, spherical equivalent, anterior and posterior elevation maps among the two groups. Conclusion: Scleroderma is a systemic disease that might lead to alterations in corneal biomechanics and refractivity, and these issues need to be investigated with more advanced studies. (Turk J Ophthalmol 2011; 41: 221-4)

Özet

Amaç: Sklerodermalı hastaların ön segment yapılarının Pentacam ile değerlendirilmesi. Gereç ve Yöntem: Kliniğimize başvuran 17 skleroderma hastasının 34 gözü (çalışma grubu), aynı yaş grubundaki 20 sağlıklı bireyin 40 gözü (kontrol grubu) ile karşılaştırıldı. Olguların en iyi düzeltilmiş görme keskinliği, göz içi basıncı ölçülerek, ön ve arka segment bakıları yapıldı. Pentacam cihazı ile olguların santral kornea kalınlığı, ön kamara hacmi, ön kamara derinliği, ön kamara açısı, ön ve arka elevasyon haritaları değerlendirildi. Parametrik değerler bağımsız t-testi ile; nonparametrik değerler Mann Whitney U testi ile değerlendirildi. Bulgular: Çalışma grubunda ortalama yaş 51,63±10,74 (28 ve 72 arası), kontrol grubunda ortalama yaş 51,42±6,74 (40 ve 66 arası) idi. Çalışma grubunda 1 erkek, 16 kadın; kontrol grubunda 4 erkek, 16 kadın olgu mevcuttu. Çalışma grubunun korneaları kontrol grubuna göre daha kırıcı bulundu (Çalışma ve kontrol grubunun ortalama K değerleri sırasıyla 44,38±1,38 ve 43,47±1,26 D, p=0,004). Çalışma grubunda tashihli görme düzeyleri kontrol grubuna göre anlamlı olarak daha düşüktü (Çalışma ve kontrol gruplarının ortalama tashihli görme düzeyleri sırasıyla 0,953±0,0915 ve 0,992±0,0408, p=0,001). Ön kamara derinliği, ön kama- ra hacmi, ön kamara açısı iki grup arasında farklılık göstermedi. Çalışma ve kontrol grubu arasında santral kornea kalınlığı, göz içi basıncı, sferik eşdeğer, ön ve arka elevasyon haritalarında fark saptanmadı. Sonuç: Skleroderma kornea biyomekaniğinde ve kırıcılığında farklılaşmaya neden olabilecek sistemik bir hastalık olup bu konunun daha ileri çalışmalarla araştırılması gerekmektedir. (Turk J Ophthalmol 2011; 41: 221-4)

🔖

Cite This Article

PALAMUR, M., YAĞCI, A., EĞRİLMEZ, S., SEYHAN, A. K. (2022). Evaluation of cornea and anterior chamber with pentacam in scleroderma cases. Türk Oftalmoloji Dergisi, Cilt: 41 - Sayı: 4, 221–224. https://ajindex.com/articles/638397

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Gilliland BC. Systemic sclerosis (scleroderma). In Braunwald E, Fauci A, Kasper D (eds): Harrison’s Internal Medicine. New York, McGraw Hill, 16th ed 2005:1979-89. Sakkas LI. New developments in the pathogenesis of systemic sclerosis. Autoimmunity. 2005;38:113-6.
  2. Tailor R, Gupta A, Herrick A, Kwartz J. Ocular manifestations of scleroderma. Surv Ophthalmol. 2009;54:292-304. Horan EC. Ophthalmic manifestations of progressive systemic sclerosis. Br J Ophthalmol. 1969;53:388-92.
  3. Mancel E, Janin A, Gosset D, Hatron PY, Gosselin B. Conjunctival biopsy in scleroderma and primary Sjogren’s syndrome. Am J Ophthalmol. 1993;115:729-9. Agatson HJ. Scleroderma with retinopathy. Am J Ophthalmol. 1953;36:120-1.
  4. Sii F, Lee GA, Snfilippo P, Stephenson DC. Pellucid marginal degeneration and scleroderma. Clin Exp Optom. 2004;87:180-4.
  5. Rabsilber TM, Khoramnia R, Auffarth GU. Anterior chamber measurements using Pentacam rotating Scheimpflug camera. J Cataract Refract Surg. 2006;32:456-9. Türkçüo¤lu P, Emre S, Göktafl A, Çankaya C, Koç B, Do¤anay S. Pupilla dilatasyonun ön kamara parametreleri üzerine etkilerinin Pentacam® sistemi ile de¤erlendirilmesi. T Klin Oftalmol. 2008;17:268-71.
  6. Tamby MC, Chanseaud Y, Guillevin L, et al. New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev. 2003;2:152-7. Ihanama ̈ki T, Pelliniemi LJ, Vuorio E. Collagens and collagen- related matrix components in the human and mouse eye. Prog Retin Eye Res. 2004;23:403-34.
  7. Meek KM, Fullwood NJ. Corneal and scleral collagens - a micro- scopist’s perspective. Micron. 2001;32:261-72.
  8. Shah S, Laiquzzaman M, Cunliffe I, Mantry S. The use of the Reichert ocular response analyser to establish the relationship between ocular hysteresis, corneal resistance factor and central corneal thickness in normal eyes. Cont Lens Anterior Eye. 2006;29:257-62.
  9. Serup L, Serup J, Hagdrup HK. Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol. 1984;62:69-74.
  10. Emre S, Kayikcioglu O, Ates H et al. Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the reichert ocular response analyzer. Cornea. 2010;29:628-31.
  11. Meinhardt B, Stachs O, Stave J, Beck R, Guthoff R. Evaluation of biometric methods for measuring the anterior chamber depth in the non-contact mode. Graefes Arch Clin Exp Ophthalmol. 2006;244:559-64.
  12. Doors M, Cruysberg LP, Berendschott TT et al. Comparison of central corneal thickness and anterior chamber depth measurem